Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 6/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.48 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.42 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.42 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | RECQL | P46063 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL971391 | 0.96 | TERT (0.58) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL971390 | 0.95 | TERT (0.56) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| SCHEMBL1470931 | 0.92 | TERT (0.53) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| SCHEMBL12532442 | 0.92 | TERT (0.53) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| Iodide SCHEMBL1470324 | 0.91 | TERT (0.51) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| SCHEMBL129138 | 0.86 | TERT (0.44) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| Bromide SCHEMBL5791833 | 0.84 | TERT (0.43) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| SCHEMBL128425 | 0.84 | TERT (0.42) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| SCHEMBL127217 | 0.83 | TERT (0.42) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL5144530 | 0.82 | TERT (0.41) | TERTL3MBTL1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1591267-B1 | Materials for imaging | HEWLETT PACKARD DEVELOPMENT CO (US) | 2007-12-05 | — | — | EP | claimed |
| US-7169542-B2 | Compositions, systems, and methods for imaging | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2007-01-30 | — | — | US | claimed |
| US-20060275693-A9 | COMPOSITIONS, SYSTEMS, AND METHODS FOR IMAGING | KASPERCHIK VLADEK | 2006-12-07 | — | — | US | claimed |
| EP-1591267-A2 | Compositions, systems, and methods for imaging | Hewlett-Packard Development Company, L.P. (US) | 2005-11-02 | — | — | EP | claimed |
| US-20050100817-A1 | Compositions, systems, and methods for imaging | HEWLETT-PACKARD DEVELOPMENT COMPANY, LP | 2005-05-12 | — | — | US | claimed |
| US-11116772-B2 | Medical methods utilising high purity diaminophenothiazinium compounds | WISTA LABORATORIES LTD. (SG) | 2021-09-14 | — | — | US | disclosed |
| US-20200268767-A1 | MEDICAL METHODS UTILISING HIGH PURITY DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LIMITED (SG) | 2020-08-27 | — | — | US | disclosed |
| EP-3564223-A1 | METHODS OF CHEMICAL SYNTHESIS AND PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) | WisTa Laboratories Ltd. (SG) | 2019-11-06 | — | — | EP | disclosed |
| EP-2322517-B1 | METHODS OF CHEMICAL SYNTHESIS AND PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) | WISTA LAB LTD (SG) | 2019-04-24 | — | — | EP | disclosed |
| US-20180078562-A1 | MEDICAL METHODS UTILISING HIGH PURITY DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. (SG) | 2018-03-22 | — | — | US | disclosed |
| US-9801890-B2 | Medical methods utilising high purity diaminophenothiazinium compounds | WISTA LABORATORIES LTD. (SG) | 2017-10-31 | — | — | US | disclosed |
| US-20170273986-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. (SG) | 2017-09-28 | — | — | US | disclosed |
| EP-1591267-B1 | Materials for imaging | HEWLETT PACKARD DEVELOPMENT CO (US) | 2007-12-05 | — | — | EP | disclosed |
| EP-1799662-A2 | METHODS OF CHEMICAL SYNTHESIS AND PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) | Wista Laboratories Ltd. (SG) | 2007-06-27 | — | — | EP | disclosed |
| US-7169542-B2 | Compositions, systems, and methods for imaging | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2007-01-30 | — | — | US | disclosed |
| US-20060287523-A1 | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) | WISTA LABORATORIES LTD. (SG) | 2006-12-21 | — | — | US | disclosed |
| US-20060275693-A9 | COMPOSITIONS, SYSTEMS, AND METHODS FOR IMAGING | KASPERCHIK VLADEK | 2006-12-07 | — | — | US | disclosed |
| WO-2006032879-A2 | METHODS OF CHEMICAL SYNTHESIS AND PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) | WISTA LABORATORIES LTD. (SG) | 2006-03-30 | — | — | WO | disclosed |
| EP-1591267-A2 | Compositions, systems, and methods for imaging | Hewlett-Packard Development Company, L.P. (US) | 2005-11-02 | — | — | EP | disclosed |
| US-20050100817-A1 | Compositions, systems, and methods for imaging | HEWLETT-PACKARD DEVELOPMENT COMPANY, LP | 2005-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11116772-B2 | Medical methods utilising high purity diaminophenothiazinium compounds | MGMT, MAPT, TST | TERT 8/4885L3MBTL1 3969/4885MEN1 205/4885 |
| US-20170273986-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | MB, TPMT, HBB | TERT 600/4885L3MBTL1 1688/4885MEN1 330/4885 |
| US-20060287523-A1 | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) | MGMT, MAPT, TST | TERT 7/4885L3MBTL1 3570/4885MEN1 128/4885 |
| US-20180078562-A1 | MEDICAL METHODS UTILISING HIGH PURITY DIAMINOPHENOTHIAZINIUM COMPOUNDS | MGMT, MAPT, TST | TERT 13/4885L3MBTL1 4142/4885MEN1 240/4885 |
| US-20200268767-A1 | MEDICAL METHODS UTILISING HIGH PURITY DIAMINOPHENOTHIAZINIUM COMPOUNDS | MGMT, MAPT, TST | TERT 13/4885L3MBTL1 4142/4885MEN1 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.